Endocrinology, Diabetes and Metabolism

54 Physicians, Trainees Feted for Humanism, Excellence
5/16/18
Fifty-four exemplary medical students, residents, fellows and faculty members have been inducted into the University at Buffalo’s Richard Sarkin Medical Emeritus Faculty Chapter of the Gold Humanism Honor Society (GHHS).
Type 2 Diabetes Study: Fiber Increased Insulin Secretion
5/2/18
Paresh Dandona, MD, PhD, has led research showing that taking a fiber supplement can help patients with Type 2 diabetes boost their insulin secretion — even after eating a high-fat, high-carbohydrate meal.
Global Study Finds Dapagliflozin Benefits Type 1 Diabetic Patients
10/12/17
A global study led by Paresh Dandona, MD, PhD, found a majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels.
12 Projects, Researchers Recognized in Medicine’s Research Day
8/23/17
A total of 12 projects and their researchers were recognized as best in their categories at the Department of Medicine’s fifth annual Research Day.
Nearly Half of IM Residents to Undertake UB Fellowship Training
3/31/17
Eleven of 25 fellowship-bound trainees from the University at Buffalo’s internal medicine residency have matched into UB programs.
12 New Faculty Join 5 Medical School Departments
2/17/17
Twelve faculty members with varied research and clinical expertise have joined the Jacobs School of Medicine and Biomedical Sciences over the past several months.
Type 2 Diabetes Drug Found to Benefit Type 1 Diabetics as Well
9/8/16
Researchers in the Division of Endocrinology, Diabetes and Metabolism have found that dapagliflozin, designed for Type 2 diabetes, can benefit patients with Type 1 diabetes.

Next> <Previous